The formation of the hand during embryogenesis, the peeling of sunburned skin and the tremor associated with Parkinson's disease all result from a common process: cell death. Cell death occurs throughout the life span of the organism and represents the ultimate differentiative decision made by cells. Insight into the process of cell death will not only contribute to our understanding of basic developmental issues, but will also facilitate the development of therapeutic interventions that could alter the course of disease. Since all cells have the genetic machinery required to commit suicide, the ability to initiate it in a lineage-specific, non-inflammatory manner would allow for the irradication of specific cancers.
chapters of this volume. Where appropriate, we will direct the reader to these other chapters for a more detailed analysis.
Reasons for programmed cell death
While PCD has recently attracted considerable interest, anecdotal observations regarding this process have been published for over a century (e.g. Beard 49 ). However, these earlier authors tended to regard the presence of dying cells within an embryo as the culling of a small number aberrant cells. It was not until the quantitative studies of Hamburger and Levi-Montalcini 50 that the magnitude of PCD was appreciated. This landmark paper demonstrated that approximately 50% of the sympathetic and motor neurons produced during embryogenesis in chicks died during a discrete developmental period prior to birth.
The observations of Hamburger and Levi-Montalcini raised a fundamental question: why would an organism waste precious resources to generate large numbers of cells that will be ultimately induced to commit suicide? The answer is that PCD confers on animals profound developmental plasticity that allows them to address a wide range of developmental problems. For example, given that the human genome has ~ 100,000 genes and the human brain possess ~ 10 bilhon cells, we do not have the genetic luxury to assign unique phenotypic properties to each individual cell. Instead, one general strategy of neurogenesis is to generate many more cells than will be needed for any given function, all of which are endowed with a common set of instructions regarding differentiation, migration, target specificity, etc. Those cells that undergo proper functional interaction with their natural cellular targets receive a retrograde signal in the form of a trophic factor, that notifies them that they are valuable and functional members of a tissue. The winners of this apparent competition survive while the losers die. In the case of the motor neurons mentioned above, only ~50% of the cells make and maintain proper synaptic contacts with target muscle fibers and survive (for review see Oppenheim   7 ). In fact, this type of target-dependence is seen in other cell types within the nervous system as well. For example, oligodendrocytes appear to compete among themselves for axons to myelinate in the optic nerve 10 . Extrapolating from these and other data, Raff 51 has suggested that all cells within a developing organism are fated to commit suicide unless granted a reprieve from other cells with which they interact.
In addition to functioning in 'systems matching' within the CNS, the massive loss of cells during embryogenesis can act to sculpt the body.
Teleologically, there are two ways to produce digits on the mammalian hand: the 'inflated glove' model or the 'selective sculpting' model. In fact it is the latter strategy that is employed. Parallel rows of cells in the limb undergo PCD to allow individual fingers to be liberated. While complete loss of these cells results in the formation of toes, partial loss, for example in aquatic birds, results in webbed feet.
PCD can function not only to remove surplus cells, but also those that have outlived their usefulness. This is seen most dramatically in animals that undergo metamorphosis, such as amphibians and insects, where structures required for larval life, such as the tadpole tail, are selectively lost during adult development 44 . However, this transient use of highly differentiated cells is not restricted to 'lower' animals. In mammals, for example, a massive regression of the mammary gland epithelium follows weaning 34 and of the endometnal lining with menstruation 32 . PCD also plays an essential role in protecting organisms from deleterious cells. For example, during T cell maturation large numbers of immature thymocytes are generated that bear self-reactive T cell receptors. Should these auto-reactive cells mature and exit the thymus, they have the potential to initiate an auto-immune response. This catastrophic outcome is prevented by inducing these self-reactive cells to die during the process of negative selection 41 .
Terms and morphologies associated with cell death
With the recent realization that the study of cell death is highly relevant to a wide variety of disciplines, many investigators have entered the field from disparate areas of science. (In fact, a recent report links earthquake activity in Mexico with defects in PCD resulting in hairlip formation in infants 52 .) As a result, some disciplines may employ different definitions or concepts associated with the same terms. For example, the term programmed cell death was coined by Lockshin and Williams 53 to describe the developmentally regulated loss of specific larval muscles following the emergence of adult moths at the end of metamorphosis. Inherent in this definition is the expectation that cells are lost in a spatially and temporally reproducible manner in response to physiological signals as part of a developmental or homeostatic process. More recently, the term PCD has been used in a wider context to refer to any cell death that is dependent on a gene-mediated 'program', independent of the signal(s) that initiates the process. Therefore, while a developmental biologist might not consider the irradiation-induced death of thymocytes an example of PCD, an immunologist might.
Programmed call death during development
Another issue is the use of the terms PCD and apoptosis. PCD is a process, while apoptosis describes a cellular morphology (defined below). In most cases, the loss of cells during PCD occurs with an apoptotic morphology but, as described below, this is not always the case. Conversely, many cells that are induced to die in response to pathological stimuli do so with an apoptotic morphology. In fact, it is possible to induce many of the structural and biochemical features of apoptosis in a cell-free system using isolated nuclei and cytoplasm from apoptotic cells (see Nicholson et al 54 ) , which is not in itself a normal developmental situation.
The term apoptosis was coined, by Kerr et al 55 , to describe a common series of morphological changes that were observed in dying cells from a wide variety of tissues and species. Typically, apoptosis involves cellular condensation, genomic DNA fragmentation, deposition of electron dense chromatin along the inner margin of the nuclear envelope, the formation of membrane 'blebs' that contain portions of the nucleus and intact organelles and, ultimately, phagocytosis of the apoptotic bodies by neighboring cells 56 . A characteristic biochemical marker for many, but not all 57 , apoptotic deaths is DNA fragmentation induced by an endogenous endonuclease 58 . This results in the cleavage of DNA into approximately 180 bp oligonucleotide fragments that reflect the spacing between individual nucleosomes. When DNA from apoptotic cells is fractionated by size m an agarose gel, a characteristic 'ladder' of fragments can be resolved. It is now possible to detect this DNA fragmentation anatomically in individual cells by performing an in situ nick translation or TUNEL (TdT-mediated dUTP-biotin nick end labeling) reaction that labels the free ends of the cleaved DNA 59 . This has provided investigators with a very powerful tool for both detecting individual apoptotic cells within a large field of cells as well as quantifying the extent of apoptotic cell death.
While an apoptotic morphology is seen in most examples of PCD, some cells display few of these features 60 . For example, when Pilar and Landmesser 61 examined the ultrastructural morphology of dying ciliary ganglion cells in the chick, they observed two distinct cell deathassociated morphologies that they termed 'nuclear' and 'cytoplasmic'. These morphologies were also subsequently observed in several other regions of the developing central nervous system where they were referred to as type 1 and type 2, respectively 62 . Although the nuclear type of cell death corresponds to apoptosis, the cytoplasmic type of cell death appears to be a distinct process. While these latter cells do undergo cytoplasmic condensation, they do not display genomic DNA fragmentation, chromatin deposition, or membrane blebbing. Instead, the initial changes associated with this form of cell death occur in the cytoplasm and include mitochondrial swelling and ribosomal breakdown Interestingly, different morphologies can be displayed by the same population of ciliary ganglion cells depending on the nature of the death stimulus. During development, ciliary ganglion cells normally display a cytoplasmic death but, when they are induced to die by removing the eye, the source of efferent target cells, the cells die by apoptosis 61 . Interestingly, this apoptotic death occurs in neurons that have not had the opportunity to interact with their target, which suggests that the choice of a cell death pathway may reflect maturation-specific option (see Cunningham   5 ). At present it is not known if these two morphologies utilize overlapping molecular components or represent fundamentally distinct processes.
Another model system that does not undergo apoptosis during PCD is the intersegmental muscle (ISM) of the moth Manduca sexta. The ISMs die following adult emergence in response to a defined hormonal trigger (reviewed in Schwartz 64 ). Dying ISMs do not display membrane blebbing, DNA fragmentation, chromatin margination or even phagocytosis (Jones, Fahrbach, and Schwartz, in preparation) 63 . Interestingly, Manduca does have the genetic machinery to use apoptosis and employs it for most, if not all, deaths within the embryo (Jones, Fahrbach and Schwartz, in preparation). Since the term PCD was coined to describe the death of these very cells and since they do not display DNA fragmentation, the use of TUNEL as the sole criterion for examining PCD has limitations. In addition, since there is great variation in the time between the initiation of cell death and the subsequent loss of the corpse in different organisms, the number of TUNEL-positive cells may be misleading as regards the magnitude of cell loss within a given tissue.
Independent of the morphology displayed, the ability of any cell to successfully undergo PCD requires three sequential processes, the cell must: (i) receive a signal to die; (ii) activate its endogenous death machinery (i.e. commit suicide); and (iii) be removed during or following death. While there is considerable variability in the mechanisms responsible for the execution of these programs among different species or even among different cells within the same organism, all three of these steps still occur.
Specific signals trigger programmed cell death
Given that PCD occurs within a developmental context, it is not surprising that the signals used to trigger this process are physiological in nature and can be used to regulate other non-lethal differentiative decisions. The molecules that trigger PCD can act at a distance, such as hormones, or more intimately via cell-cell contact. Any molecule that can provide information to cells can be harnessed as a cell death signal. In addition, presumably any cell in the body can be exposed to the signal, but only a subset of cells are programmed by lineage-specific decisions will 'interpret' this signal as an inducer of death. For example, during amphibian metamorphosis, all the cells of the body are presumably exposed to elevations in thyroid hormone levels. Many cells are unresponsive to this signal. Some, such as the limb buds, respond by proliferating and differentiation, while others, such as muscles in the tail, initiate death.
One tissue that has provided key insights into the regulation of death versus survival is the vertebrate nervous system. While far from completely characterized, it is clear that the survival of most cells in the nervous system is dependent on target-derived trophic molecules. The first data supporting a role for the existence of a 'trophic factor' were generated by Levi-Montalcini and Hamburger with their demonstration that the survival of sympathetic neurons was dependent on nerve growth factor (NGF) 65 . How then do target cells regulate the production and/or availability of trophic factors? Current data suggest that target cells may initially produce sufficient amounts of trophic factor(s) to support a large population of interacting neurons. As functional synaptic contacts are established, and the target cell is electrically stimulated, the production and/or availability of trophic factor is dramatically reduced. Consequently, only the subset of neurons that have made appropriate contacts with targets survive. In the case of the neuromuscular system, drugs that block synaptic transmission, such as curare, rescue motor neurons from cell death 66 , while electrical stimulation of the hind limb prior to innervation reduces motor neuron survival 67 . Other inter-and intracellular interactions can also influence the survival of neurons. In fact, a neuron's survival represents a balance between appropriate afferent input and target interaction, with imbalances at either end of the circuit resulting in death (reviewed in 5   -7 ). It has been suggested that these various sources of stimulation modulate intracellular calcium levels, such that modest elevations in [Ca 2+ ], are correlated with survival, while dramatic increases result in death (see Franklin and Johnson 68 ). As mentioned above, cell-cell contact working through specialized membrane receptors can also function to regulate PCD. The best characterized example of this process is negative selection in the mouse thymus 41 . Stromal cells within the thymus present 'self peptides within the groove of the major histocompatability complex (MHC) to passing immature thymocytes. Those T cells that have matured properly but fail to recognize the presented antigens survive and exit to the periphery to await future stimulation by novel pathogens. T cells bearing receptors that recognize self-antigens are induced to die. In fact, it is estimated that upwards of 90% of the T cells that migrate into the thymus never exit. It is important to note that once the cell has been positively selected, TCR engagement results in proliferation or anergy, not death. Therefore, a stimulus that can be coupled to death in one developmental context may serve an entirely different role for the same cell in at different developmental stage.
One membrane receptor system that has received intense investigation for the study of cell death is the Apo-1/Fas receptor (reviewed in Nagata and Goldstein 69 ). This receptor system appears to function in both negative selection in the thymus and clonal deletion of activated lymphocytes in the periphery. The Apo-1/Fas receptor was discovered when two independent laboratories identified monoclonal antibodies that could induce apoptosis in specific target cells 70 -71 . Apo-1/Fas has been cloned and shown to be a member of the NGF/tumor necrosis receptor gene family 71 . Recently, the ligand for Apo-1/Fas, Fas-ligand, has been shown to be related to tumor necrosis factor 72 . Cross-linking of the Apo-1/Fas receptor with either the natural ligand or monoclonal antibodies results in the initiation of apoptosis by generating an intracellular complex of the C-terminal tails of the receptor. These sequences in turn contain 'death domains' that are protein-protein interaction motifs that allow for the formation of a signalling complex that results in the activation of the ICE family proteases (see below) leading to death (reviewed by Barinaga 73 ). Interestingly, the Apo-1/Fas signalling pathway appears to be an ancient one during phylogeny. A low molecular weight protein in Drosophila, reaper 74 , shares structural homology with the death domain of Apo-1/Fas 75 . Loss of genomic sequences that include reaper (as well as the death-inducing genes head involution defective 76 and grim 77 ), results in the abolition of all embryonic cell deaths, while ectopic expression of reaper induces apoptosis. One interesting possibility is that during evolution, reaper-like death domains became coupled to specific extracellular receptors, thus allowing specific signals to rapidly induce apoptosis without a need for synthesizing this signal transduction pathway 75 . Evidence from a number of studies has suggested that imbalances in cell cycle regulators can also function as inducers of apoptosis. For example, expression of the oncogene c-myc drives cells into mitosis, while removal of extracellular growth factors results in growth arrest. If c-myc is expressed in cells and then serum is removed, the cells rapidly initiate apoptosis 78 . One interpretation is that the cells are receiving conflicting growth signals which lead them to commit suicide so as to reduce the risk of generating defective progeny. This obviously would help reduce the likelihood of malignancy in an organism. One of the key regulators of this cell cycle-mediated death is the tumor suppressor p53.
Cells with deficiencies in p53 no longer display Gl arrest or undergo apoptosis when treated with DNA damaging agents, such as irradiation or chemotherapeutic agents 79 -80 . Additional evidence for cell death resulting from an aborted cell cycle is found in the rat ventral prostate. Following castration, prostate cells begin to replicate their DNA prior to initiating the DNA degradation that occurs with apoptosis 81 . An imbalance of the cell cycle may also be responsible for peripheral neuronal death as a result of trophic factor withdrawal 82 . In superior cervical ganglion cells, there is an increase in cyclin Dl mRNA NGF removal. Other cyclins, which are required components of the cell cycle, are neither present nor up-regulated in these post-mitotic cells. One interpretation is that loss of trophic support induces neurons to unsuccessfully attempt to re-enter the cell cycle, resulting in death.
Cells undergoing programmed cell death commit suicide
Like other differentiative decisions, the ability of cells to undergo PCD almost always require changes in the steady-state expression of specific cell death-associated genes (reviewed in Schwartz and Osborne 83 ). The first support for this hypothesis came from studies in the 1960s, when investigators treated developing animals with actinomycin D and cycloheximide, inhibitors of RNA and protein synthesis, respectively. Instead of being noxious, these metabolic inhibitors prevented cell death. Since then, several laboratories have used a variety of genetic and molecular techniques to isolate genes whose expression seems to be important for PCD.
The best evidence for the role of cell death genes comes from the pioneering studies of Horvitz and his colleagues working with the freeliving nematode Caenorhabditis elegans (reviewed in Ellis et al SA ) . In these animals, 131 of the normal 1090 cells die during development. Using a genetic screen, mutations in 14 different genes were identified that altered the normal pattern of cell loss, and suggested a hierarchy of genes involved in cell death 84 . One gene, ced-9 (cell death abnormal), functions to protect cells from cell death: gain of function mutations block most PCDs while loss of functional alleles are lethal due to massive ectopic cell loss 85 . This gene was shown to be both a structural and functional homolog of the mammalian anti-apoptosis gene, bcl-2 86 -88 . Ced-9 appears to function upstream of two essential cell death genes, ced-3 and ced-4. Loss of function mutations in either of these genes blocks all programmed cell deaths 89 . While the identity of ced-4 appears to be novel, ced-3 is the nematode homolog of a family of mammalian proteases whose best characterized member is interleukin-l/?-converting enzyme (ICE) 90 . ICE-like cysteine proteases have now been shown to have key roles in the cell death pathway of numerous cell types including: motor neurons, sympathetic ganglion cells, fibroblasts, interdigital cells, mammary epithelium, lymphocytes, and fly omatidia (reviewed in Schwartz and Milligan 91 ; Fig. 1 ). While a number of ICE family proteases have been identified and implicated in cell death, those that are more ced-9-like, including: CPP-32, ICE-lapIII, MCH 4 and 5, may be more involved in the actual cell death pathway. ICE family proteases appear to be present in cells as inactive pro-enzymes that require proteolytic cleavage by other ICE family members (or themselves) for activation. (Interestingly, some ICE proteases can be proteolytically activated by granzyme B, a serine protease found in cytotoxic T lymphocytes [CTLs] which can rapidly induce apoptosis in target cells 92 .) Since ICE proteases are already resident in condemned cells, the ability of RNA and protein synthesis inhibitors to block PCD presumably occurs because cells can not generate the proteins required to couple specific extracellular signals in a lineage-specific manner to the resident 'death' program. For example, it was recently demonstrated that FLICE/MACH, an ICE family protease that possesses a death domain can couple APO-I/Fas activation to the activation of ICE proteases and subsequent apoptosis 93 -94 . Pharmacological studies have shown that there is sequential activation of ICE-like and CPP32-like proteases during Fas/APO-1 mediated death 95 . It appears that a proteolytic cascade, reminiscent of the blood clotting cascade, leads to apoptosis.
There is intense interest in the target substrates for the deathassociated ICE family proteases (reviewed in Schwartz and Milligan 91 ). The best characterized of these substrates is PARP (poly-ADP-ribose polymerase) whose hydrolysis in apoptosis is thought to block both attempts at DNA repair and reductions in cellular pools of NAD (nicotinamide adenine dinucleotide) 96 . At present, it is unclear if the loss of PARP or any other specific ICE family protease substrate represents an essential step in killing or if apoptosis results from cumulative impact of losing a wide range of important cellular proteins.
Other proteases have also been implicated in the death of cells. When the intersegmental muscles of M. sexta die (described above), there are exponential increases in the levels of: polyubiquitin mRNA, ubiquitin protein, ubiquitin-protein conjugates, proteasome activity, the synthesis of specific proteasome subunits and apparent ubiquitin/proteasome mediated degradation of cellular proteins . Expression of all of these ubiquitin/proteasome pathway components are regulated by the same hormonal signal that regulates ISM death, suggesting that this pathway is important for the PCD of these cells. In separate studies, Delic et al 101 have demonstrated that antisense inhibition of polyubiquitin expression blocks the irradiation-induced death of human peripheral lymphocytes. Extending these studies, two laboratories have demonstrated that inhibitors of the proteasome block the death of immature thymocytes 102 and sympathetic neurons 103 in response to a wide variety of agents. These drugs blocked not only PCD, but also activation of ICE proteases, suggesting that the ubiquitin/proteasome pathway plays a key regulatory role early in the cell death cascade. Other proteases, such as cathepsin D, have also been implicated in the regulation of apoptosis. Deiss et a/ 104 transfected cells with constructs expressing antisense cRNA and looked for recombinants that blocked Fas/Apo-1-mediated death. One such recombinant encoded cathepsin D. Conversely, transfection of cells with cathepsin D induced apoptosis in cultured cells. One word of caution that must be offered for many of these studies is that a variety of proteases that are not involved in apoptosis may have the ability to initiate apoptosis by proteolytically activating true cell death regulators.
As reviewed more thoroughly in a preceding chapter, a spontaneous mutation in humans that has provided great insight into the regulation of PCD results in the development of Burkitt's lymphoma 105 -107 . This t(14;18) translocation brings the bcl-2 (B cell lymphoma) gene under the control of the immunoglobulin enhancer. In these individuals, B cells over-produce bcl-2 which, in turn, blocks the normally occurring apoptotic death of many B cells. Both genetic and biochemical studies have suggested that bcl-2 acts up-stream of ICE protease family activation. In fact, bcl-2 is able to block the activation of CPP-32 in a cell-free apoptotic model 108 . How bcl-2 works is still unknown, but some data suggest that it may act as a free radical scavenger 109 . In fact, mice homozygous for targeted germ-line deficiencies in bcl-2 survive to birth, although they subsequently die approximately 2-3 weeks later with phenotypic defects consistent with a loss of protection from free radical damage 110 . In addition to its role in preventing oxidative stressinduced cell death, bcl-2 has also been shown to prevent cell death induced by over-expression of ICE proteases 111 . Furthermore, recent studies have demonstrated that there is a family of bcl-2-related proteins that appear to interact as both positive and negative regulators of cell death 112 -113 . These data support the hypothesis that cell death is regulated by several factors and pathways.
Another biochemical event that may be involved in the regulation of cell death is a decrease in glutathione 114 " 117 . For example, there is a decrease in glutathione in rat pheochromocytoma cells (PC12 cells) following NGF withdrawal, which, if prevented, blocks subsequent cell death 115 ' 116 . Decreases in glutathione have been hypothesized to increase free radical generation which, in turn, triggers death. This correlates with the apparent role of bcl-2 in squelching free radical activity 109 . The decrease in glutathione may play a role in the activation of specific proteases. For example, a glutathione disulfide has been demonstrated to inhibit ICE directly 118 . Consequently, decreased cellular levels of glutathione could then activate ICE proteases, resulting in death. These data suggest that there are multiple regulatory steps along the cascade of reactions that leads to ICE protease activation and subsequent cell death.
Taking a large volume of research together, the following model emerges. Cells possess receptors for physiological signals that can be coupled to a wide variety of phenotypic response pathways, including death. In the latter case, the cells express specific molecules that are required for coupling extracellular signals to the resident cell death pathway. Separate components of this pathway act as positive and negative regulators of cell death, and a balance of these influences ultimately determines if the cell will kill itself. If it 'decides' to die, inactive pro-enzymes are activated by hydrolysis which, in turn, results in the activation of ICE proteases which, in turn, have a wide range of substrates available to them. The loss of these critical cell regulators then ultimately results in the collapse of cellular function and subsequent death. The fate of the resulting corpse is addressed below.
Resolution of cell death
While much attention has been devoted to understanding the signals and molecular pathways that mediate PCD, less attention has been focused on how the body deals with removing the cellular debris that follows death. This is a non-trivial consideration given the tremendous number of cells that undergo PCD and the profound inflammatory nature of intracellular constituents. Consequently, phagocytosis of the corpse appears to be an essential component of almost all cell deaths 119 . (It is interesting to note that the non-apoptotic PCD of the ISMs of moths occurs without phagocytosis [Jones, Fahrbach and Schwartz, in preparation]: instead, the dying cells consume themselves without an apparent breach in the sarcolemma.) Understanding the cellular, molecular and biochemical mechanisms of how dead cells are disposed of will provide powerful tools for understanding issues relevant to development, aging and pathology.
Phagocytosis is a key component of apoptosis and is regulated by a series of proteins. The genetics of this process is best understood in C. elegans, where 7 genes have been identified in the process of phagocytosis of the corpse 119 . These genes appear to represent two distinct complementation groups: one potentially representing cell surface ligands that identify the cell as a corpse; and the other as receptors for these signals on the phagocytosing cell. While mutations in these genes prevent corpse removal, they have no impact on the death process itself. Instead, loss-of-function mutations in these genes produce nematodes that are littered with persistent corpses.
As mentioned above, cellular constituents are highly inflammatory in vertebrates. Consequently, if cells undergoing PCD were allowed to lyse, as occurs with necrosis, the cellular (involving neutrophils, eosinophils, macrophages and lymphocytes) and humoral (such as histamine, prostaglandins, leukotrienes, lymphokines and antibodies) components of the inflammatory response could be disastrous to surrounding cells. Although dying cells have been found to be phagocytosed by neighbors, the predominant professional scavenger is the macrophage 55 . In fact, almost every morphological study examining tissues that display PCD describes the presence of macrophages (reviewed in Milligan 120 ). Phagocytosis of cells undergoing PCD is so efficient that dying cells are often found within macrophages prior to the final death of the cell in both invertebrates 121 and vertebrates 122 . The recognition and subsequent phagocytosis of dead cells is discussed elsewhere in this issue. However, in order for large number of corpses to be phagocytosed, macrophages must be recruited to the area of cell death. For example, given the specificity of macrophage recruitment to areas within the CNS undergoing PCD, some investigators have hypothesized that degenerating neuronal elements secrete a chemotactic signal for macrophages 122 " 124 , one of which has been recently identified 125 . Lesions to the visual cortex at birth result in massive and rapid invasion of macrophages into the degenerating dorsal lateral geniculate nucleus (dLGN) 124 . Since macrophages are not evident within the dLGN during the first few days of normal postnatal development, these cells must migrate in from a distant site. A factor, brain derived chemotactic factor (BDCF), exhibits opioid-like activity that initiates macrophage chemotaxis via a receptor with pharmacological characteristics of a delta opioid receptor 125 . Present experimental evidence suggests that this opioid works in association with other factors to initiate the migration of macrophages to sites of injury-induced cell death in the nervous system. In invertebrates, such as Drosophila, macrophage-hke cells are also recruited to regions of PCD in the developing CNS 121 , although the identity of this putative signal has yet to be determined.
As suggested above, phagocytic cells appear to function as a consequence of cell death, not a cause of it. For example, in both nematodes 119 and moths (Jones, Fahrbach and Schwartz, unpublished), cell death occurs independently of phagocytosis. The same appears to be true of mammals where, for example the initial morphological changes associated with death in dLGN neurons occur prior to massive influx of macrophage 124 . However, a recent report has presented evidence that macrophages may serve not just to remove debris, but also to kill target cells in the developing mouse eye 126 . In this study, the authors used a transgenic mouse to target diphtheria toxin to subsets of mature macrophages, including those found in the eye cavity. In contrast to wild-type mice, the hyaloid vasculature persisted in these transgenic animals, suggesting that, in the absence of hyalocytes (macrophages), cell death of the hyloid vasculature was not initiated. However, there is always the possibility that cell death still occurred, but in the absence of phagocytosis, normal gross tissue morphology was retained. Furthermore, m some systems, it appears that the macrophage response following cell death may facilitate tissue remodeling during development 124 .
Summary
Programmed cell death occurs in almost every tissue during development and often throughout the life span of the organism. In addition, the pathways that regulate PCD appear to be conserved across phylogeny. In the simplest terms, PCD requires that a cell receive a signal to die, activate the biochemical and molecular cascade that leads to death, and then dispose of the corpse. With the identification of the key regulatory steps involved in PCD, it should be possible to initiate or inhibit these processes. This control over the life and death of cells in a lineagespecific manner will have profound implications for both our understanding of development and our treatment of disease.
